Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Bright Minds Biosciences Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −1 vs. Q1 2022
- Shares held
- 487.7K
- +73.5K (+17.7%) vs. Q1 2022
- Total value
- $399.0K
- −$229.0K (−36.5%) vs. Q1 2022
- New holders
- 0
- 3 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DRUG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 99 | $653.8M |
| Q1 2026 | 94 | $670.3M |
| Q4 2025 | 74 | $514.9M |
| Q3 2025 | 64 | $366.1M |
| Q2 2025 | 47 | $137.0M |
| Q1 2025 | 34 | $188.4M |
| Q4 2024 | 31 | $176.4M |
| Q3 2024 | 6 | $229.8K |
| Q2 2024 | 6 | $208.2K |
| Q1 2024 | 7 | $255.6K |
| Q4 2023 | 8 | $329.8K |
| Q3 2023 | 6 | $309.2K |
| Q2 2023 | 8 | $326.3K |
| Q1 2023 | 9 | $256.7K |
| Q4 2022 | 9 | $309.6K |
| Q3 2022 | 14 | $509.0K |
| Q2 2022 | 10 | $399.0K |
| Q1 2022 | 11 | $628.0K |
| Q4 2021 | 9 | $2.93M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Bright Minds Biosciences Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 289,576 | $237.0K | 0.07% | +82,860+40.1% | Added |
| Ikarian Capital, LLC | 105,958 | $86.0K | 0.04% | 00.0% | Unchanged |
| Jane Street Group, LLC | 24,700 | $20.0K | 0.00% | −10.0% | Reduced |
| Quattro Financial Advisors LLC | 21,150 | $17.0K | 0.01% | 00.0% | Unchanged |
| Checchi Capital Advisers, LLC | 14,138 | $14.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 11,801 | $9.00K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 11,040 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,277 | $6.00K | 0.00% | +3,826+110.9% | Added |
| Royal Bank of Canada | 1,579 | $1.00K | 0.00% | +1,340+560.7% | Added |
| Aspire Private Capital, LLC | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,561−100.0% | Sold out |